Sign In
Buy CNS
$80.79
-1.71 (-2.07%)
At Close: Jul 21, 2026
HYOGO, Japan--(BUSINESS WIRE)--JCR announced that the Company presented preclinical data from its novel adeno-associated virus (AAV) gene therapy research programs at ASGCT 2025.
CNS Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Update
08:05am, Friday, 16'th May 2025
Cash expected to fund operations into the second half of 2026 Advancing development strategy for lead program TPI 287 to commence Phase 2 study around year end 2025 for treatment of glioblastoma multi
Cohen & Steers and IDR Investment Management Partner to Launch Tactical Listed and Private Real Estate Strategy
09:00am, Wednesday, 14'th May 2025
NEW YORK , May 14, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today that the firm, in partnership with IDR Investment Management, LLC ("IDR"), has launched an innovative real est
CNS Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
09:35am, Tuesday, 13'th May 2025
HOUSTON, TX / ACCESS Newswire / May 13, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for pri
CNS Pharmaceuticals Acquires Orphan Drug Designation for Novel, Late Stage Abeotaxane, TPI 287
07:00am, Tuesday, 13'th May 2025
Company advancing plans to develop TPI 287, a novel, late stage abeotaxane that appears to cross the blood-brain barrier and has published clinical efficacy data in glioblastoma multiforme (GBM) Manag
Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for April 2025
04:28pm, Thursday, 08'th May 2025
NEW YORK , May 8, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $87.5 billion as of April 30, 2025, a decrease of $70 million from assets
Corero's 2025 Threat Intelligence Report Reveals Strategic Shifts in DDoS Tactics and Rising Operational Strain for Defenders
08:00am, Wednesday, 07'th May 2025
LONDON , May 7, 2025 /PRNewswire/ -- Today, Corero Network Security (AIM: CNS) (OTCQX: DDOSF), the distributed denial of service (DDoS) protection specialists, released its 2025 Threat Intelligence R
Cohen & Steers, Inc. Declares Quarterly Dividend
04:18pm, Thursday, 01'st May 2025
NEW YORK , May 1, 2025 /PRNewswire/ -- The Board of Directors of Cohen & Steers, Inc. (NYSE: CNS) declared a cash dividend for the second quarter of 2025 in the amount of $0.62 per share of common st
Serina Therapeutics to Present at JonesResearch Virtual CNS Day
06:00am, Tuesday, 29'th Apr 2025
HUNTSVILLE, AL, April 29, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ dru
Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)
06:23pm, Monday, 28'th Apr 2025
NEW YORK , April 28, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources
Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)
06:07pm, Monday, 28'th Apr 2025
NEW YORK , April 28, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of
Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a)
06:07pm, Monday, 28'th Apr 2025
NEW YORK , April 28, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of
Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
06:05pm, Monday, 28'th Apr 2025
NEW YORK , April 28, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the s
Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)
06:04pm, Monday, 28'th Apr 2025
NEW YORK , April 28, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the d
Voyager Next-Generation CNS Capsids Featured at ASGCT 28th Annual Meeting
04:30pm, Monday, 28'th Apr 2025
- Oral presentation on tau silencing gene therapy VY1706, which has previously shown up to 73% knockdown of tau mRNA in NHPs in the CNS following a single IV dose of 1.3e13 vg/kg -
